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Edited by Horst FeldmannAbstract Knowledge of the protein and peptide content in a
tissue or a body ﬂuid is vital in many areas of medical and
biomedical sciences. Information from proteomic and peptidomic
studies may reveal alterations in expression due to, e.g., a disease
and facilitate the understanding of the pathophysiology and the
identiﬁcation of biological markers. In this minireview, we
discuss miniaturized proteomic and peptidomic approaches that
have been applied in our laboratory in order to investigate the
protein and peptide contents of body ﬂuids (such as plasma,
cerebrospinal and amniotic ﬂuid), as well as extracted tissues.
The methods involve miniaturized liquid separation, i.e., capil-
lary liquid chromatography and capillary electrophoresis, com-
bined with high resolution mass spectrometry (MS), i.e., Fourier
transform ion cyclotron resonance MS. These approaches
provide the opportunity to analyze samples of small volumes
with high throughput, high sensitivity, good dynamic range and
minimal sample handling. Also, the experiments are relatively
easy to automate.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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spectrometry1. Introduction
Proteomics and peptidomics, the studies of all proteins and
peptides expressed in an organism, a tissue or a body ﬂuid at a
given times are ﬁelds of great importance in biological and
medical research. Investigations of the protein and peptide
composition of a body ﬂuid, the sequences and structures of
these analytes as well as possible post-translational modiﬁca-
tions need to be performed before a description of a proteome
or peptidome can be provided. It should be noted that prote-
omes and peptidomes are not constant; they are inﬂuenced by,
e.g., metabolism, disease states, stress, and drug interactions.
The possibility to monitor alterations in protein and peptide
patterns, that can be correlated to a certain disease, is valuable
for a deeper understanding of its etiology and will facilitate its
diagnosis.
Several aspects have to be taken into account when devel-
oping or choosing a method for proteomic studies. The sam-* Corresponding author. Fax: +46-18-471-3692.
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are present in a wide concentration range. Analytes of very
diﬀerent chemical properties, e.g., hydrophobicity, size and pI,
should be detected in the same experiment. Hence, sensitive
and non-discriminating methods need to be applied. The
analysis time for running one sample should be short and the
method easy to automate. Also, the experiments generate an
enormous amount of data, which means that there are high
demands on data-handling and bioinformatics.
The traditional proteomic approach starts with separation
of the proteins by two-dimensional sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (2D-PAGE) [1,2], where the
proteins are separated in two dimensions with respect to their
isoelectrical points (pI-values) and sizes, respectively. The
spots on the gels are then selected and the proteins are enzy-
matically digested before they are analyzed, e.g., by MALDI-
TOF mass spectrometry (MS). This method has proved to be
of great use for many applications. Alternative approaches
that are becoming more popular are based on liquid separation
in one or several dimensions followed by MS or tandem mass
spectrometry (MS/MS) [3]. The experiments start with enzy-
matic digestion (often tryptic cleavage) of all proteins present
in the sample, whereby the resulting peptides are separated and
detected. The advantages of these methods are that they are
generally much faster and easier to automate than the 2D-
PAGE approach. In ‘‘shot-gun’’ proteomics, the identiﬁcation
of the proteins is based on sequences information on the
tryptic peptides. Alternatively, accurate mass tags can be used
to identify the components.
There is no clear cut-oﬀ deﬁnition between proteins and
peptides, but most of those molecules referred to as peptides
have masses of <20 kDa. The traditional 2D-approach is re-
stricted to proteins in the mass range of around 10–200 kDa.
Hence, this tool cannot be used in the ﬁeld of peptidomics.
Instead, the classical procedure for investigations of pepti-
domes involves puriﬁcation of peptides from tissue extracts
using several consecutive liquid chromatography (LC)-steps
[4,5]. After puriﬁcation, the peptides can be characterized us-
ing either Edman degradation or MS. Today, MS or prefer-
entially MS/MS is the dominating technique for investigation
of peptides. There is no need for complete puriﬁcation of the
components and the amount of sample required for the anal-
ysis is minor.
In this minireview, we will describe and discuss some non-
gel-based methods that we utilize in our laboratory for the
identiﬁcation and characterization of proteins and peptides inblished by Elsevier B.V. All rights reserved.
M. Ramstr€om, J. Bergquist / FEBS Letters 567 (2004) 92–95 93complex biological mixtures. These methods are based on
packed capillary LC or capillary electrophoresis (CE) coupled
on-line to high resolution MS, Fourier transform ion cyclotron
resonance (FTICR) MS. LC and CE are based on two diﬀerent
separation mechanisms, in LC the analytes are separated with
respect to their hydrophobicity, while size and charge are the
important parameters in CE separation. The combination of
both methods with electrospray (ESI) MS is today well-
established tool for detection and identiﬁcation of proteins and
peptides [6,7]. Great advantages of the approaches are the low
sample volume required for one experiment. While capillary
LC has a higher peak capacity, CE beneﬁts from being faster
and has high separation eﬃciency. Hence, the methods should
be regarded as alternatives and complements to each other.
Previously, the combinations of LC and CE with FTICR MS
have proved to be useful for the investigation of microbial and
mouse cell proteomes [8,9]. The research in our laboratory
concerns mainly studies of the protein and peptide composi-
tion of diﬀerent mammalian (e.g., human) body ﬂuids and
tissues.Fig. 1. An overview of an LC-FTICR mass chromatogram of a tryptic
digest of CSF. Typically, 4000–6000 peptides are detected in one
experiment. The most abundant peptides are those from albumin.2. Materials and methods
A general description of the experimental procedures used for
FTICR MS studies of body ﬂuids and tissues is given below.
2.1. Sample handling
The samples discussed in this review are tryptic global digests of
body ﬂuids, e.g., plasma [10,11], CSF [6,11,12], salivary, urine [11] and
extracted peptides from, e.g., pancreatic islets [13]. For a general de-
scription of sample preparation and handling, see the review by
Bergquist et al. [11].
2.2. Liquid chromatography
The rather conventional HPLC-system used in these experiments
consisted of two pumps (JASCO 1580, JASCO Japan) that delivered
mobile phase gradients at a ﬂow rate of 1 lL/min. Typically, 10 lL of
the sample volume was injected into a six-port injector valve (Valco
Instruments Co. Inc., Schenkon, Switzerland). The peptides were
separated on a 10-cm long in-house packed capillary C18-column,
packing material £5 lm ODS-AQ (YMC Europe, Schermbeck,
Germany). They passed a UV-detector as a controlled step before they
were electrosprayed on-line into the FTICR MS.
2.3. Capillary electrophoresis
The CE instrumentation used in our laboratory was designed and
built in-house [6]. A Pyrex glass cylinder (diameter 5 cm, length 10 cm,
volume 0.2 L) was ﬁtted between two PVC plastic lids with gas-proof
Teﬂon O-ring seals. Gas-proof tightened PEEK connections for the
high voltage cable, inlet end of the capillary, and gas inlet were drilled
into the top lid. A sample carousel of Plexiglas was mounted on a PVC
piston running through the lid (also through a gastight seal), enabling
fast manual sample switching. A vent valve inserted into the top lid
adjusted the applied pressure. An outer safety shell of Plexiglas was
mounted around the Pyrex glass cylinder. The high voltage power
supply (Bertan, Hicksville, NY) operated in constant negative voltage
mode. Fused silica capillary 25 lm i.d. 360 lm o.d. (Polymicro
Technologies, Tucson, AZ) was cut into 100 cm lengths.
2.4. Mass spectrometry
The electrospray was maintained using the in-house constructed
Black Dust (polyimide-graphite) sheathless electrospray emitters [14]
in all experiments described in this review. The 9.4 T FTICR mass
spectrometer (Bruker Daltonics, Billerica, MA) used in the studies is
described in detail elsewhere [15]. In the LC experiments, a mass
spectrum was typically collected during 10 s and 256 spectra were
collected in each experiment. In the CE-runs, a mass spectrum was
recorded during a few seconds.3. Results
3.1. FTICR MS of body ﬂuids
Many projects in our laboratory concern the development of
methods to identify and characterize biomarkers in body ﬂuids
of clinical interest. The tool that we have used for detection is
high resolution MS, e.g., FTICR MS. In addition to ultra-high
resolution, FTICR MS provides very high mass accuracy and
high sensitivity [16,17]. When using this approach, the mass
measurement errors in a well-calibrated spectrum are on the
ppm-level and hence the possible peptides corresponding to a
certain detected mass are limited. Our approach starts with the
simultaneous cleavage of all proteins in the samples, followed
by MS detection of the peptides.
Direct infusion experiments of tryptic digests of plasma,
CSF, salivary and urine, demonstrated the possibility to detect
several interesting proteins in all body ﬂuids under study [11],
taking advantage of the high resolving power and the mass
accuracy of the MS. This approach is fast, a mass spectrum
can be obtained within seconds, and the experimental setup is
rather straightforward. A direct infusion mass spectrum of a
tryptic digested body ﬂuid will hence give an overview of its
main components and the complexity of the sample. This
should be regarded as a fast screening method. To further
improve the sensitivity of the analysis, LC [10,12] and CE [18]
have been coupled prior to the mass spectrometer. When in-
troducing a separation step prior to MS, ion suppression in the
spray will be reduced and the spectra will be less complex.
Hence, the possibility to observe peptides from low abundant
components will increase and also the elution times of the
peptides provide additional information. The information
achieved from one experiment is very extensive. For example,
LC-FTICR experiment of CSF typically results in 4000–7000
detected peptides, while around 1500 peptides are detected in a
CE-experiment. Hence, the LC-approach provides more in-
formation and accepts higher sample load, while a CE exper-
iment is faster to perform. Fig. 1 shows a typical mass
chromatogram of tryptic digested CSF.
A great advantage of the presented method is that it is rather
general and does not need to be optimized for diﬀerent body
ﬂuids. LC-FTICR MS experiments have been performed on
tryptic digests of CSF [12], plasma [10] and also on amniotic
ﬂuid (unpublished data), utilizing similar sample preparation
94 M. Ramstr€om, J. Bergquist / FEBS Letters 567 (2004) 92–95and experimental setup. The protein patterns from these bio-
logical mixtures are diverging but show some similarities. In all
cases, the dominating peptides are those from the abundant
protein HSA. These peptides are spread throughout the mass
chromatogram and can be used as internal calibrants. In all
studies, proteins of clinical interest were identiﬁed. The num-
ber of identiﬁed proteins were comparable to those achieved
running a traditional 2D-gel experiment. In the plasma anal-
ysis, the LC-FTICR MS approach was demonstrated to be a
good complement or an alternative to LC-iontrap MS/MS
[10]. The results from these two studies also agreed well, sev-
eral diﬀerent groups of proteins were identiﬁed, e.g., transport
proteins, immunoglobulins, glycoproteins, coagulation factors,
enzymes and inhibitors.
3.2. Data handling
As described above, the analysis of a tryptic digest from a
complex biological sample results in mass chromatograms of
thousands of peaks. The mass measurement error using an
FTICR could be at the ppm-level. It should, however, be
mentioned that to achieve this, a proper calibration needs to be
performed. It is a challenging task to calibrate a mass chro-
matogram from a CE- or a LC-run, since the total charge
varies during the chromatographic run and local space charge
eﬀects will inﬂuence the calibration. The approach that we use
is to calibrate internally with respect to known tryptic or en-
dogenous peptides in the body ﬂuid or tissue extract. To cor-
rectly identify proteins in the ﬂuid, reliable data algorithm for
identiﬁcation needs to be constructed. When analyzing a
peptide pattern using accurate mass measurement, a number of
tryptic peptides from one protein need to be detected. In the
algorithm that has been used for identiﬁcation so far, the mass
measurement error distributions and the distribution in the
protein sequence of the detected peptides have been taken into
account. Also, the separation step provides additional infor-
mation that can be utilized to improve the identiﬁcation [19].
When these algorithms were applied, around 40 proteins could
be identiﬁed at a signiﬁcance level >95% from the 6000
peptides in the LC-run and 30 proteins from the 1500 peptides
in the CE experiment of CSF proteins. The number of iden-
tiﬁed peptides is in the same order as from traditional 2D-gel
electrophoresis [20–22]. However, the time required for one
experiment is shorter. The concentration range of the identiﬁed
proteins covers four orders of magnitudes.
3.3. On-line electron capture dissociation and nozzle-skimmer
fragmentation
Tandem mass spectrometry is a powerful tool for the iden-
tiﬁcation and characterization of proteins and peptides. A
fragmentation method that is so far only applied in FTICR
MS is called electron capture dissociation (ECD). This tech-
nique provides a ‘‘mild’’ fragmentation, allowing for frag-
mentation without the loss of labile post-translational
modiﬁcation. This is an attractive alternative to more estab-
lished methods. In our laboratory we have shown, for the ﬁrst
time, the possibility to combine high rate ECD with on-line LC
[23] and CE [24] for the analysis of tryptic digests of proteins as
well as standard peptides. Sequence information from ECD
was successfully provided in alternating spectra. We have also
applied the LC-ECD FTICR MS approach when studying an
extract of peptides from mouse pancreatic islets, and on-line
nozzle-skimmer fragmentation was applied to the same sample[13]. Sequence information on components derived from the
main components was achieved taking both approaches.
Complementary information was achieved due to the diﬀerent
fragmentation mechanisms of the two methods. However, the
sensitivity of ECD needs to be further improved before lower
abundant components in the samples can be sequenced and
studied. If this can be done, we believe in the combination of
on-line separation ECD and nozzle-skimmer fragmentation as
being a very powerful approach to achieve useful comple-
mentary sequence information on peptide extracts as well as
tryptic digests.
3.4. Quantiﬁcation of proteins and peptides
Investigation of a proteome does not only concern what
proteins are present, but also in what concentration they are
expressed. There are several ways to quantify proteins using
MS. One way to perform relative quantiﬁcation of proteins in,
e.g., plasma would be to normalize them to coeluting peptides
of albumin. HSA is known to vary by less than 7% between
individuals. For better quantiﬁcation labelling methods need
to be applied.
Labelling markers can be divided into two subgroups; those
that label only speciﬁc amino acid residues in the peptides and
those that label chemical groups present in all peptides. The
latter techniques are referred to as being global. A novel global
labelling technique for comparative proteomics was tested for
the analysis of tryptic digests of standard proteins. The
markers used were the Quantiﬁcation-Using-Enhanced-Signal-
Tags (QUEST) markers, which are covalently linked to the
lysines and N-terminal of all peptides [25]. These markers had
previously been described to be useful in MALDI MS exper-
iments, and our study is the ﬁrst one using ESI and FTICR
MS. Both direct infusion experiments and on-line LC-FTICR
MS were tested on tryptic digests of standard proteins of
known concentration ratios [26]. High sequence coverage of
the QUEST-labelled proteins was observed and the results
indicated that this method was useful for determining the
relative quantities of the proteins. The advantage of using a
global labelling technique is that all peptides in a mixture can
be quantiﬁed. However, the complexity of the samples in-
creases since two pools of peptides labelled with diﬀerent
markers are added. When choosing a method for quantiﬁca-
tion, these aspects need to be taken into account. We believe
that the usage of these markers has a great potential. The next
step will be to use the markers in comparative peptidomics and
proteomics.4. Concluding remarks
High resolution MS is a powerful tool in proteomics. Re-
search in our laboratory relies on the combination of LC and
CE with FTICR MS. The great advantages of these ap-
proaches are that small volumes are needed, that they are fast
and rather general. Our results clearly demonstrate the possi-
bility to identify proteins of clinical interest in several body
ﬂuids. An application for these novel techniques should be to
search for biomarkers of, e.g., a disease. The results from the
previous experiments have encouraged us to start a compara-
tive proteomic study of CSF from patients suﬀering from a
neurodegenerative disease and CSF from controls. Mass
chromatograms of the two groups have been recorded and
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show promises that this approach, after further evaluation, can
be used as a diagnostic tool (manuscript submitted to Pro-
teomics). It should also be interesting to include the QUEST-
markers in this study, to monitor possible disease-speciﬁc
alterations. On-line fragmentation, nozzle-skimmer fragmen-
tation and ECD can be applied to identify these proteins or
peptides and to characterize post-translational modiﬁcations.
Future approaches on the sample side may include single cell
proteomics, combining the high sensitivity of our methodology
with laser capture microdissection technology, probing of
biochemical functions following selected signalling pathways
with cellular systems. On the separation side, we are investi-
gating further miniaturization including on-chip LC and CE
approaches, multidimensional LC or LC-CE systems as well as
monolith columns and sol–gel beds. The challenge in proteo-
mics and peptidomics is to combine the correct techniques with
the proper samples and analytes. Many mass spectrometric
approaches have proved to be outstanding in this research.
The integration of proteomics and bioinformatics still needs to
be taken to the next level, and is today the bottleneck for many
applications.
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